Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
29.79
+0.97 (3.37%)
Aug 15, 2025, 1:41 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
U.S. Bracing & Support | 469.32M | Log In | Log In | Log In | Log In | Upgrade |
U.S. Bracing & Support Growth | 5.28% | Log In | Log In | Log In | Log In | Upgrade |
U.S. Other P&R | 270.74M | Log In | Log In | Log In | Log In | Upgrade |
U.S. Other P&R Growth | -0.06% | Log In | Log In | Log In | Log In | Upgrade |
International P&R | 357.90M | Log In | Log In | Log In | Log In | Upgrade |
International P&R Growth | 3.07% | Log In | Log In | Log In | Log In | Upgrade |
U.S. Reconstructive | 505.62M | Log In | Log In | Log In | Log In | Upgrade |
U.S. Reconstructive Growth | 13.97% | Log In | Log In | Log In | Log In | Upgrade |
International Reconstructive | 504.05M | Log In | Log In | Log In | Log In | Upgrade |
International Reconstructive Growth | 48.60% | Log In | Log In | Log In | Log In | Upgrade |
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Prevention & Recovery Capital Expenditures | 34.00M | Log In | Log In | Log In | Log In | Upgrade |
Prevention & Recovery Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Reconstructive Capital Expenditures | 146.71M | Log In | Log In | Log In | Log In | Upgrade |
Reconstructive Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Prevention & Recovery Adjusted EBITDA | 159.60M | Log In | Log In | Log In | Log In | Upgrade |
Prevention & Recovery Adjusted EBITDA Growth | 7.42% | Log In | Log In | Log In | Log In | Upgrade |
Reconstructive Adjusted EBITDA | 216.92M | Log In | Log In | Log In | Log In | Upgrade |
Reconstructive Adjusted EBITDA Growth | 40.96% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 1.25B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 7.42% | Log In | Log In | Log In | Log In | Upgrade |
Foreign Locations | 861.95M | Log In | Log In | Log In | Log In | Upgrade |
Foreign Locations Growth | 26.01% | Log In | Log In | Log In | Log In | Upgrade |